Neil Dahiya

Delhi Court Urges Government to Consider Inclusion of Ichthyosis as a Disability under RPwD Act

The Delhi High Court has prompted the central authority to contemplate a submission from the Center for Ichthyosis Related Members Foundation, an organization devoted to supporting individuals with Ichthyosis or those connected to them. The plea seeks recognition of Ichthyosis […]

Delhi Court Urges Government to Consider Inclusion of Ichthyosis as a Disability under RPwD Act Read More »

Genethon and Hansa Initiate Phase 2 Trial of Imlifidase as Pre-Therapy to GNT-0003 for Advanced Crigler-Najjar Syndrome

Hansa Biopharma, an innovative commercial biopharmaceutical entity, together with Genethon, a leader in the sphere of gene therapy for rare genetic disorders, announced the launch of GNT-018-IDES. This is a phase 2 clinical trial aimed at individuals with Crigler-Najjar syndrome

Genethon and Hansa Initiate Phase 2 Trial of Imlifidase as Pre-Therapy to GNT-0003 for Advanced Crigler-Najjar Syndrome Read More »

Sharp Rise in Lung Cancer Among Non-Smokers in India Highlights Urgent Need for Advanced Diagnostic Tools: Dr. Badiger

India is observing an unexpected surge in lung cancer cases among individuals who have never smoked, challenging traditional views and causing concern within the medical field. Dr. Aravind Badiger, the technical director of BDR Pharmaceuticals, highlights this trend as a

Sharp Rise in Lung Cancer Among Non-Smokers in India Highlights Urgent Need for Advanced Diagnostic Tools: Dr. Badiger Read More »

AIPAC and MP IDMA Set to Host Symposium on ‘Dissolution Science and Technology’ in Indore on December 12

The Consortium of the All India Pharmaceutical Association (AIPAC), in collaboration with the Society for Pharmaceutical Dissolution Science (SPDS) and the Indian Pharmaceutical Manufacturers Association’s Madhya Pradesh division (MP IDMA), will be hosting a one-day symposium focused on ‘Dissolution Science

AIPAC and MP IDMA Set to Host Symposium on ‘Dissolution Science and Technology’ in Indore on December 12 Read More »

MediBuddy Introduces IHCC, a Network for Seamless Insurance-Linked Healthcare Services

MediBuddy has unveiled the India Health Care Collaborators (IHCC), a platform designed to bring together insurance companies, brokers, and healthcare providers. This initiative is focused on enhancing access to a secure, cashless primary healthcare system. The new platform, called BuddyCare,

MediBuddy Introduces IHCC, a Network for Seamless Insurance-Linked Healthcare Services Read More »

Revolutionizing Drug Development: Nyctea Technologies Introduces Electro-Purification

**Swedish Innovator Nyctea Technologies Seeks Growth in Drug Purification Technologies** Nyctea Technologies, a Swedish startup focused on both deeptech and medtech, is setting its sights on expanding into new markets with its pioneering biomolecular purification system. Originating as a project

Revolutionizing Drug Development: Nyctea Technologies Introduces Electro-Purification Read More »

Medexus and medac Finalize Amendments to US Treosulfan Deal, Outlining Milestone Benchmarks and Payment Plan

Medexus Pharmaceuticals, recognized as a prominent specialty pharmaceutical company with a robust North American presence and an expanding range of unique treatments for rare disorders, recently declared that it has reached a fourth amendment to its exclusive licensing agreement from

Medexus and medac Finalize Amendments to US Treosulfan Deal, Outlining Milestone Benchmarks and Payment Plan Read More »